Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Bonecker, S."" wg kryterium: Autor


Tytuł :
Tunicata, Thaliacea, Pyrosomatidae, Pyrosomella verticillata (Neumann, 1909): First record from the southwest Atlantic Ocean.
Autorzy :
Bonecker, S. L. C.
Carvalho, P. F.
Pokaż więcej
Temat :
Biology (General)
QH301-705.5
Źródło :
Check List, Vol 4, Iss 3, Pp 272-274 (2008)
Opis pliku :
electronic resource
Relacje :
http://www.checklist.org.br/getpdf?NGD122-08; https://doaj.org/toc/1809-127X
Dostęp URL :
https://doaj.org/article/33a9eeffb7364840a0477d67366cfa7d
Czasopismo naukowe
Tytuł :
Chaetognatha, Spadellidae, Paraspadella nana Owre, 1963: New occurrence from the southwest Atlantic Ocean.
Autorzy :
Bonecker, S. L. C.
Avila, L. R. M.
Arruda, M. R.
Pokaż więcej
Temat :
Biology (General)
QH301-705.5
Źródło :
Check List, Vol 6, Iss 4, Pp 628-629 (2010)
Opis pliku :
electronic resource
Relacje :
http://www.checklist.org.br/getpdf?NGD045-09; https://doaj.org/toc/1809-127X
Dostęp URL :
https://doaj.org/article/8187030dac0444dda1eb51d1e8fc3724
Czasopismo naukowe
Tytuł :
1029P - Frequency and clinical impact of compound mutation in chronic myeloid leukemia patients resistant to tyrosine kinase inhibitor
Autorzy :
Bonecker, S.
Pokaż więcej
Źródło :
In Annals of Oncology October 2018 29 Supplement 8
Czasopismo naukowe
Tytuł :
miRNome profiling of LSC-enriched CD34 CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.
Autorzy :
Ruiz MS; Centro de Investigaciones Oncológicas-Fundación Cáncer, Ciudad Autónoma de Buenos Aires, Argentina.
Sánchez MB; Centro de Investigaciones Oncológicas-Fundación Cáncer, Ciudad Autónoma de Buenos Aires, Argentina.
Bonecker S; Centro de Transplante de Medula Óssea, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Furtado C; Programa de Genética, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Koile D; Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, Ciudad Autónoma de Buenos Aires, Argentina.
Yankilevich P; Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, Ciudad Autónoma de Buenos Aires, Argentina.
Cranco S; Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Argentina.
Custidiano MDR; Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Argentina.
Freitas J; Hospital Nacional Posadas, Buenos Aires, Argentina.
Moiraghi B; Hospital J. M. Ramos Mejía, Ciudad Autónoma de Buenos Aires, Argentina.
Pérez MA; Hospital Interzonal General de Agudos, Buenos Aires, Argentina.
Pavlovsky C; Fundaleu, Ciudad Autónoma de Buenos Aires, Argentina.
Varela AI; Hospital J. M. Ramos Mejía, Ciudad Autónoma de Buenos Aires, Argentina.
Ventriglia V; Hospital Nacional Posadas, Buenos Aires, Argentina.
Sánchez Ávalos JC; Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Argentina.
Larripa I; Instituto de Medicina Experimental, CONICET/Academia Nacional de Medicina, Ciudad Autónoma de Buenos Aires, Argentina.
Zalcberg I; Centro de Transplante de Medula Óssea, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Mordoh J; Centro de Investigaciones Oncológicas, Fundación Cáncer, Buenos, Aires, Argentina.; IIBBA-CONICET, Fundación Instituto Leloir, Buenos, Aires, Argentina.; Instituto Alexander Fleming, Buenos, Aires, Argentina.
Valent P; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Bianchini M; Centro de Investigaciones Oncológicas-Fundación Cáncer, Ciudad Autónoma de Buenos Aires, Argentina.
Pokaż więcej
Źródło :
Frontiers in pharmacology [Front Pharmacol] 2021 Jan 11; Vol. 11, pp. 612573. Date of Electronic Publication: 2021 Jan 11 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansion.
Autorzy :
Chicaybam L; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.; Vice-Presidency of Research and Biological Collections (VPPCB) - Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
Abdo L; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Viegas M; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Marques LVC; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
de Sousa P; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Batista-Silva LR; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Alves-Monteiro V; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Bonecker S; Bone Marrow Transplantation Unit, Specialized Laboratories, Laboratory of Molecular Biology, National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Monte-Mór B; Bone Marrow Transplantation Unit, Specialized Laboratories, Laboratory of Molecular Biology, National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Bonamino MH; Molecular Carcinogenesis Program - Research Coordination - Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil. .; Vice-Presidency of Research and Biological Collections (VPPCB) - Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil. .
Pokaż więcej
Źródło :
Gene therapy [Gene Ther] 2020 Feb; Vol. 27 (1-2), pp. 85-95. Date of Electronic Publication: 2020 Jan 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunotherapy, Adoptive/*methods
Leukemia, B-Cell/*therapy
Transposases/*therapeutic use
Animals ; Antigens, CD19/genetics ; Cell Line, Tumor ; Cytotoxicity, Immunologic/genetics ; Cytotoxicity, Immunologic/immunology ; Female ; Genetic Vectors/genetics ; Genetic Vectors/therapeutic use ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy ; Receptors, Antigen, T-Cell/genetics ; T-Lymphocytes/immunology ; Transposases/genetics ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Early molecular response ≤1% has strong prognostic impact for CML patients that switch to second-line therapy with BCR-ABL1 ≤10% and no major molecular response.
Autorzy :
Bonecker S; Laboratory of Molecular Biology, Bone Marrow Transplant Centre (CEMO), Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Carvalho G; University Hospital, Rio de Janeiro, Federal University (UFRJ), Rio de Janeiro, Brazil.
Dobbin J; Haematology Service, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Zalcberg I; Laboratory of Molecular Biology, Bone Marrow Transplant Centre (CEMO), Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Schaffel R; University Hospital, Rio de Janeiro, Federal University (UFRJ), Rio de Janeiro, Brazil.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (4), pp. 770-772. Date of Electronic Publication: 2018 Oct 18.
Typ publikacji :
Letter
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy
Adult ; Aged ; Dasatinib/therapeutic use ; Drug Substitution ; Female ; Fusion Proteins, bcr-abl/metabolism ; Humans ; Imatinib Mesylate/therapeutic use ; Male ; Middle Aged ; Pyrimidines/therapeutic use ; Survival Analysis ; Young Adult
Opinia redakcyjna
Tytuł :
An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation.
Autorzy :
Maia RC; Laboratório de Hemato-Oncologia Celular e Molecular, Programa de Hemato-Oncologia Molecular, Coordenação de Pesquisa, Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil; Serviço de Hematologia, Hospital do Câncer I, INCA, RJ, Brazil. Electronic address: .
Bonamino MH; Programa de Carcinogênese Molecular, Coordenação de Pesquisa, INCA, RJ, Brazil; Fundação Oswaldo Cruz, Vice-presidência de Pesquisa e Laboratórios de Referência, RJ, Brazil.
Robaina MC; Laboratório de Hemato-Oncologia Celular e Molecular, Programa de Hemato-Oncologia Molecular, Coordenação de Pesquisa, Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.
Amaral N; Laboratório de Biologia Molecular, Centro de Transplante de Medula Óssea, INCA, RJ, Brazil.
Bonecker S; Laboratório de Biologia Molecular, Centro de Transplante de Medula Óssea, INCA, RJ, Brazil.
Zalcberg IR; Laboratório de Biologia Molecular, Centro de Transplante de Medula Óssea, INCA, RJ, Brazil.
Klumb CE; Laboratório de Hemato-Oncologia Celular e Molecular, Programa de Hemato-Oncologia Molecular, Coordenação de Pesquisa, Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil; Serviço de Hematologia, Hospital do Câncer I, INCA, RJ, Brazil.
Pokaż więcej
Źródło :
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2015 Dec; Vol. 55 (4), pp. 347-50. Date of Electronic Publication: 2015 Jul 21.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
Janus Kinase 2/*genetics
Primary Myelofibrosis/*diagnosis
Primary Myelofibrosis/*genetics
Female ; Follow-Up Studies ; Humans ; Infant ; Phenotype
Czasopismo naukowe
Tytuł :
Differential expression of SHP-1 in chronic myeloid leukemia.
Autorzy :
Kaeda J; Hämatologie, Onkologie und Tumorimmunologie, Medizinische Klinik m.S., Campus Virchow Klinikum, Charité, Universitätsmedizin Berlin , Berlin , Germany.
Neuman D
Bonecker S
Mills K
Oberender C
Amini L
Ringel F
Serra A
Schwarz M
Dörken B
Zalcberg I
le Coutre P
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2015 May; Vol. 56 (5), pp. 1547-9. Date of Electronic Publication: 2014 Oct 30.
Typ publikacji :
Letter
MeSH Terms :
Gene Expression Regulation, Leukemic*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics
Protein Tyrosine Phosphatase, Non-Receptor Type 6/*genetics
Fusion Proteins, bcr-abl/genetics ; Humans ; RNA, Messenger/genetics
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies